These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 20838622)

  • 21. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease.
    Stott DJ; MacIntosh G; Lowe GD; Rumley A; McMahon AD; Langhorne P; Tait RC; O'Reilly DS; Spilg EG; MacDonald JB; MacFarlane PW; Westendorp RG
    Am J Clin Nutr; 2005 Dec; 82(6):1320-6. PubMed ID: 16332666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized FAVORIT Ancillary Cognitive Trial.
    Scott TM; Rogers G; Weiner DE; Livingston K; Selhub J; Jacques PF; Rosenberg IH; Troen AM
    J Prev Alzheimers Dis; 2017; 4(3):174-182. PubMed ID: 29182708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study.
    Brady CB; Gaziano JM; Cxypoliski RA; Guarino PD; Kaufman JS; Warren SR; Hartigan P; Goldfarb DS; Jamison RL
    Am J Kidney Dis; 2009 Sep; 54(3):440-9. PubMed ID: 19628319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A controlled trial of homocysteine lowering and cognitive performance.
    McMahon JA; Green TJ; Skeaff CM; Knight RG; Mann JI; Williams SM
    N Engl J Med; 2006 Jun; 354(26):2764-72. PubMed ID: 16807413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dihydrofolate reductase 19-bp deletion modifies the beneficial effect of B-vitamin therapy in mild cognitive impairment: pooled study of two randomized placebo-controlled trials.
    Wu Y; Smith AD; Bastani NE; Refsum H; Kwok T
    Hum Mol Genet; 2022 Mar; 31(7):1151-1158. PubMed ID: 34788822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
    Ebbing M; Bleie Ø; Ueland PM; Nordrehaug JE; Nilsen DW; Vollset SE; Refsum H; Pedersen EK; Nygård O
    JAMA; 2008 Aug; 300(7):795-804. PubMed ID: 18714059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
    ; Armitage JM; Bowman L; Clarke RJ; Wallendszus K; Bulbulia R; Rahimi K; Haynes R; Parish S; Sleight P; Peto R; Collins R
    JAMA; 2010 Jun; 303(24):2486-94. PubMed ID: 20571015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamins B(12), B(6), and folic acid for cognition in older men.
    Ford AH; Flicker L; Alfonso H; Thomas J; Clarnette R; Martins R; Almeida OP
    Neurology; 2010 Oct; 75(17):1540-7. PubMed ID: 20861451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people.
    Kwok T; Lee J; Law CB; Pan PC; Yung CY; Choi KC; Lam LC
    Clin Nutr; 2011 Jun; 30(3):297-302. PubMed ID: 21216507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
    Albert CM; Cook NR; Gaziano JM; Zaharris E; MacFadyen J; Danielson E; Buring JE; Manson JE
    JAMA; 2008 May; 299(17):2027-36. PubMed ID: 18460663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals.
    Clarke R; Bennett D; Parish S; Lewington S; Skeaff M; Eussen SJ; Lewerin C; Stott DJ; Armitage J; Hankey GJ; Lonn E; Spence JD; Galan P; de Groot LC; Halsey J; Dangour AD; Collins R; Grodstein F;
    Am J Clin Nutr; 2014 Aug; 100(2):657-66. PubMed ID: 24965307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of long-term nutraceutical and dietary supplement use on cognition in the elderly: a 10-year systematic review of randomised controlled trials.
    D'Cunha NM; Georgousopoulou EN; Dadigamuwage L; Kellett J; Panagiotakos DB; Thomas J; McKune AJ; Mellor DD; Naumovski N
    Br J Nutr; 2018 Feb; 119(3):280-298. PubMed ID: 29310724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials.
    Kishi T; Matsunaga S; Oya K; Ikuta T; Iwata N
    Int J Neuropsychopharmacol; 2015 Jun; 18(12):. PubMed ID: 26091818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial.
    Gommans J; Yi Q; Eikelboom JW; Hankey GJ; Chen C; Rodgers H;
    BMC Geriatr; 2013 Sep; 13():88. PubMed ID: 24004645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.
    Jack CR; Wiste HJ; Vemuri P; Weigand SD; Senjem ML; Zeng G; Bernstein MA; Gunter JL; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS;
    Brain; 2010 Nov; 133(11):3336-48. PubMed ID: 20935035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homocysteine, B Vitamins, and Cognitive Impairment.
    Smith AD; Refsum H
    Annu Rev Nutr; 2016 Jul; 36():211-39. PubMed ID: 27431367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-
    Włoczkowska O; Perła-Kaján J; Smith AD; de Jager C; Refsum H; Jakubowski H
    Alzheimers Dement (N Y); 2021; 7(1):e12159. PubMed ID: 33816764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials.
    Ford AH; Almeida OP
    J Alzheimers Dis; 2012; 29(1):133-49. PubMed ID: 22232016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly.
    Ellinson M; Thomas J; Patterson A
    J Hum Nutr Diet; 2004 Aug; 17(4):371-83; quiz 385-7. PubMed ID: 15250847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.